Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Troxacitabine, a DNA polymerase inhibitor, is potentially used for the treatment of acute myeloid leukemia (AML). In comparison with gemcitabine, troxacitabine was equally active against MiaPaCa and was more efficacious against Panc-01.
Description | Troxacitabine, a DNA polymerase inhibitor, is potentially used for the treatment of acute myeloid leukemia (AML). In comparison with gemcitabine, troxacitabine was equally active against MiaPaCa and was more efficacious against Panc-01. |
Synonyms | BCH-4556, SGX-145, SGX145, SPD-758, BCH4556, beta-L-OddC |
Molecular Weight | 213.19 |
Formula | C8H11N3O4 |
CAS No. | 145918-75-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
H2O: Insoluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Troxacitabine 145918-75-8 Others BCH-4556 SGX-145 SGX145 SPD-758 BCH 4556 BCH4556 SPD 758 beta-L-OddC SPD758 b-L-OddC β-L-OddC SGX 145 inhibitor inhibit